Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in pre-clinical models of non-Hodgkin's lymphoma
Repetto-Llamazares, Ada H. V., Malenge, Marion M., O'Shea, Adam, Eiríksdóttir, Bergthóra, Stokke, Trond, Larsen, Roy H., Dahle, JosteinLangue:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.13139
Date:
July, 2018
Fichier:
PDF, 910 KB
english, 2018